Otolaryngology · Huntsville, AL
NPI
1962593442
Since 2006
Specialty
Otolaryngology
Code 207Y00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1963 Memorial Parkway SW, Suite 5
Huntsville, AL, 35801
Phone (256) 536-9300
Groups this clinician bills Medicare through
Medicare paid, 2024
$142K
2,903 services
Medicare patients, 2024
615
Average age 76
Drug cost, 2024
$49K
1,882 prescriptions
Company payments, 2025
$3,930
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William J McFeely Jr. was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 1,065 times for 49 patients. In total William J McFeely Jr. billed 2,903 services in 57 codes, and Medicare paid $142K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-22.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,065 | 49 | $0.09 | $92.95 |
| 99214 Office E&M - Established | Office | 409 | 276 | $84.94 | $35K |
| 99213 Office E&M - Established | Office | 293 | 215 | $57.38 | $17K |
| 69801 Other Organ Systems | Office | 167 | 49 | $177.04 | $30K |
| G0268 Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 132 | 131 | $34.06 | $4,496 |
| 95165 Treatment - Miscellaneous | Office | 120 | 12 | $9.25 | $1,110 |
| 92504 E&M - Miscellaneous | Office | 90 | 63 | $18.37 | $1,653 |
| 92567 Test - Miscellaneous | Office | 74 | 73 | $10.88 | $805 |
| 69222 Other Organ Systems | Office | 50 | 20 | $136.98 | $6,849 |
| 92540 Vision, Hearing, and Speech Services | Office | 40 | 40 | $73.83 | $2,953 |
| 92546 Vision, Hearing, and Speech Services | Office | 40 | 40 | $88.48 | $3,539 |
| 92537 Test - Miscellaneous | Office | 39 | 39 | $28.18 | $1,099 |
| 92584 Test - Miscellaneous | Office | 34 | 34 | $74.92 | $2,547 |
| 99203 Office E&M - New | Office | 31 | 31 | $70.43 | $2,183 |
| 99215 Office E&M - Established | Office | 30 | 29 | $118.58 | $3,557 |
By year: 2022 $174K for 2,129 services; 2023 $142K for 2,554 services; 2024 $142K for 2,903 services.
Medicare prescription drug claims, 2024
In 2024, the drug William J McFeely Jr. prescribed most often to Medicare patients was Indapamide, with 214 prescriptions and refills. In total William J McFeely Jr. wrote 1,882 Medicare prescriptions that cost $49K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Indapamide Generic | 214 | 456 | 64 | $4,156 |
| Diazepam Generic | 208 | 208 | 36 | $438 |
| Azelastine Hcl Generic | 193 | 260 | 83 | $6,037 |
| Fluticasone Propionate Generic | 118 | 188 | 51 | $2,155 |
| Ciprofloxacin-Dexamethasone Ciprofloxacin Hcl/Dexameth | 111 | 112 | 60 | $18K |
| Alprazolam Generic | 89 | 89 | 15 | $363 |
| Meclizine Hcl Generic | 78 | 94 | 38 | $929 |
| Ondansetron Odt Ondansetron | 76 | 81 | 29 | $1,080 |
| Ofloxacin Generic | 71 | 73 | 46 | $1,881 |
| Amitriptyline Hcl Generic | 70 | 114 | 15 | $451 |
| Lorazepam Generic | 52 | 52 | 12 | $149 |
| Promethazine Hcl Generic | 43 | 47 | Under 11 | $354 |
| Montelukast Sodium Generic | 37 | 95 | 14 | $427 |
| Dexamethasone Generic | 34 | 48 | 16 | $87.69 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 34 | 34 | 33 | $371 |
Brand drugs: 57 claims; generic drugs: 1,825 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William J McFeely Jr. $3,930 ($70.48 in general payments such as food, travel and fees and $3,860 for research) from 5 companies. The largest payer was Neurent Medical Limited with $3,860.
| Company | Payments | Amount |
|---|---|---|
| Neurent Medical Limited | 2 | $3,860 |
| Kerecis Limited | 1 | $31.96 |
| Smith+Nephew, Inc. SNN | 1 | $20.98 |
| KARL STORZ Endoscopy-America | 1 | $17.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.